Aspirin’s Decline in Heart Prevention: Who Still Benefits?
New data show daily baby aspirin use for preventing cardiovascular disease has fallen from 7.2% to 3.2% since 2018 as guidelines shifted to emphasize bleeding risks; aspirin is no longer broadly recommended for primary prevention in most adults, with the strongest benefit only for those who’ve already had a heart attack, stroke, or requiring a stent, and decisions should be individualized with a clinician alongside continued risk-factor management.